Oxford Biomedica PLC
24 December 2001
Oxford BioMedica ('the Company')
Director's Shareholding
On 24th December 2001 the Company allotted 94,300 ordinary shares of 1p
('Ordinary Shares') to Sharon Wood, the wife of Andrew Wood, a director of the
company, pursuant to the exercise of options over 1p ordinary shares as
follows:
Options Exercise price (p)
Sharon Wood 56,335 15.5p
37,965 11.5p
Total 94,300
In addition to the above options over 160,161 ordinary shares granted to
Sharon Wood have lapsed.
As a result of the above Andrew Wood's interest in ordinary shares is as
follows:
Ordinary Shares 116,800 0.5% of issued share capital
Options over Ordinary Shares 1,742,901
FURTHER INFORMATION
Andrew Wood, Oxford BioMedica 01865 783000
24th December, 2001
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.